Molecular pathogenesis of emphysema

Journal of Clinical Investigation

Volumn 118, Issue 2, 2008, Pages 394-402

  Taraseviciene Stewart, Laimute ^a   Voelkel, Norbert F ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENE EXPRESSION; HUMAN; HYPERINFLATION; IMMUNITY; INNATE IMMUNITY; LUNG EMPHYSEMA; LUNG INJURY; LUNG STRUCTURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENESCENCE; TISSUE REPAIR;

ALPHA 1-ANTITRYPSIN; ANIMALS; DISEASE MODELS, ANIMAL; GUINEA PIGS; HUMANS; IMMUNITY, NATURAL; MICE; OXIDATIVE STRESS; PEPTIDE HYDROLASES; PULMONARY EMPHYSEMA; RATS;

EID: 38849196926     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31811     Document Type: Review

References (125)

1. Fulton, J.F. 1930. Selected readings in the history of physiology. Charles C. Thomas. Springfield, Illinois, USA. 307-315.
2. Snider, G.L., Kleinerman, J., Thurlbeck, W.M., and Bengali, Z.H. 1985. The definition of emphysema. Am. Rev. Respir. Dis. 132:182-185.
3. Laennec, R.T. 1819. De auscultation médiate; ou, Traité du diagnostic del maladies des poumons et du coeur. Brosson et Chaude. Paris, France.
4. Laennec, R.T. 1834. A treatise on the diseases of the chest. Longman. London, United Kingdom.
5. Filley, G.F. 1967. Emphysema and chronic bronchitis: clinical manifestations and their physiologic significance. Med. Clin. North Am. 51:283-292.
6. Sahebjami, H. 1992. Emphysema-like changes in HIV. Ann. Intern. Med. 116:876.
7. Tuder, R.M., and Voelkel, N.F. 2002. The pathobiology of chronic bronchitis and emphysema. In Chronic obstructive lung diseases. N.F. Voelkel and W. MacNee, editors. B.C. Decker. London, United Kingdom. 90-113.
8. Finkelstein, R., et al. 1995. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 152:267-276.
9. Cote, C., Zilberberg, M.D., Mody, S.H., Dordelly, L.J., and Celli, B. 2007. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur. Respir. J. 29:923-929.
10. Engelen, M.P., Schols, A.M., Lamers, R.J., and Wouters, E.F. 1999. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin. Nutr. 18:275-280.
11. Sabit, R., et al. 2007. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175:1259-1265.
12. Celli, B.R. 2006. Chronic obstructive pulmonary disease: from unjustified nihilism to evidence-based optimism. Proc. Am. Thorac. Soc. 3:58-65.
13. Murray, C.J., and Lopez, A.D. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 349:1498-1504.
14. Sullivan, S.D., Ramsey, S.D., and Lee, T.A. 2000. The economic burden of COPD. Chest. 117:5S-9S.
15. Symposium of Emphysema and the "Chronic Bronchitis" Syndrome. 1959. Am. Rev. Respir. Dis. 80:1-213.
16. Fletcher, C., and Peto, R. 1977. The natural history of chronic airflow obstruction. Br. Med. J. 1:1645-1648.
17. Abbey, D.E., et al. 1998. Long-term particulate and other air pollutants and lung function in non-smokers. Am. J. Respir. Crit. Care Med. 158:289-298.
18. Jimenez, L.A., et al. 2000. Activation of NF-kappaB by PM(10) occurs via an iron-mediated mechanism in the absence of IkappaB degradation. Toxicol. Appl. Pharmacol. 166:101-110.
19. Karakatsani, A., et al. 2003. Air pollution in relation to manifestations of chronic pulmonary disease: a nested case-control study in Athens, Greece. Eur. J. Epidemiol. 18:45-53.
20. Joos, L., Pare, P.D., and Sandford, A.J. 2002. Genetic risk factors. In Chronic obstructive lung diseases. N. Voelkel and W. MacNee, editors. B.C. Decker. London, United Kingdom. 56-64.
21. Ferrarotti, I., et al. 2003. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur. Respir. J. 21:444-449.
22. Demeo, D.L., et al. 2006. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am. J. Hum. Genet. 78:253-264.
23. Ito, I., et al. 2005. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am. J. Respir. Crit. Care Med. 172:1378-1382.
24. Gauldie, J., et al. 2006. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc. Am. Thorac. Soc. 3:696-702.
25. Jankowich, M.D., Polsky, M., Klein, M., and Rounds, S. 2007. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 730:1-7.
26. Gross, P., Babyak, M.A., Tolker, E., and Kaschak, M. 1964. Enzymatically produced pulmonary emphysema: a preliminary report. J. Occup. Med. 6:481-484.
27. Eriksson, S. 1964. Pulmonary emphysema and alpha1-antitrypsin deficiency. Acta Med. Scand. 175:197-205.
28. Agusti, A., MacNee, W., Donaldson, K., and Cosio, M. 2003. Hypothesis: does COPD have an autoimmune component? Thorax. 58:832-834.
29. Aoshiba, K., Yokohori, N., and Nagai, A. 2003. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol. 28:555-562.
30. Grumelli, S., et al. 2004. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 1:e8.
31. Zhang, X., Shan, P., Jiang, G., Cohn, L., and Lee, P.J. 2006. Toll-like receptor 4 deficiency causes pulmonary emphysema. J. Clin. Invest. 116:3050-3059.
32. Morris, D.G., and Sheppard, D. 2006. Pulmonary emphysema: when more is less. Physiology (Bethesda). 21:396-403.
33. Yoshida, T., and Tuder, R.M. 2007. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol. Rev. 87:1047-1082.
34. Calabrese, F., et al. 2005. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir. Res. 6:14.
35. Kanazawa, H., and Yoshikawa, J. 2005. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest. 128:3191-3197.
36. Tuder, R.M., et al. 2003. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol. 29:88-97.
37. Vandivier, R.W., Henson, P.M., and Douglas, I.S. 2006. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 129:1673-1682.
38. Nyunoya, T., et al. 2006. Cigarette smoke induces cellular senescence. Am. J. Respir. Cell Mol. Biol. 35:681-688.
39. Tsuji, T., Aoshiba, K., and Nagai, A. 2006. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med. 174:886-893.
40. Taraseviciene-Stewart, L., et al. 2006. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc. Am. Thorac. Soc. 3:687-690.
41. Voelkel, N.F. 2002. Historical overview of emphysema. In Chronic obstructive lung diseases. N.F. Voelkel and W. MacNee, editors. B.C. Decker. London, United Kingdom. 1-6.
42. Hogg, J.C., et al. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350:2645-2653.
43. Mercer, B.A., Kolesnikova, N., Sonett, J., and D'Armiento, J. 2004. Extracellular regulated kinase/mitogen activated protein kinase is upregulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J. Biol. Chem. 279:17690-17696.
44. Taraseviciene-Stewart, L., et al. 2005. An animal model of autoimmune emphysema. Am. J. Respir. Crit. Care Med. 171:734-742.
45. Houghton, A.M., et al. 2006. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest. 116:753-759.
46. Ofulue, A.F., and Ko, M. 1999. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am. J. Physiol. 277:L97-L105.
47. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:2002-2004.
48. Eidelman, D., et al. 1990. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications. Am. Rev. Respir. Dis. 141:1547-1552.
49. Finkelstein, R., Fraser, R.S., Ghezzo, H., and Cosio, M.G. 1995. Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care Med. 152:1666-1672.
50. Owen, C.A. 2005. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2:373-385.
51. Fischer, U., Janicke, R.U., and Schulze-Osthoff, K. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10:76-100.
52. Elkington, P.T., and Friedland, J.S. 2006. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 61:259-266.
53. Greenlee, K.J., Werb, Z., and Kheradmand, F. 2007. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol. Rev. 87:69-98.
54. D'Armiento, J., Dalal, S.S., Okada, Y., Berg, R.A., and Chada, K. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell. 71:955-961.
55. Foronjy, R.F., Okada, Y., Cole, R., and D'Armiento, J. 2003. Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L727-L737.
56. Segura-Valdez, L., et al. 2000. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 117:684-694.
57. Stone, P.J., et al. 1995. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 152:157-162.
58. Wright, J.L., and Churg, A. 1995. Smoke-induced emphysema in guinea pigs is associated with morphometric evidence of collagen breakdown and repair. Am. J. Physiol. 268:L17-L20.
59. Zheng, T., et al. 2005. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J. Immunol. 174:8106-8115.
60. Wang, B., et al. 2006. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J. Biol. Chem. 281:6020-6029.
61. Demura, Y., Taraseviciene-Stewart, L., Scerbavicius, R., Tuder, R.M., and Voelkel, N.F. 2004. N-acetylcysteine treatment protects against VEGF-receptor blockade-related emphysema. COPD. 1:25-32.
62. Kasahara, Y., et al. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
63. Petrache, I., et al. 2006. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am. J. Respir. Crit. Care Med. 173:1222-1228.
64. Tuder, R.M., Petrache, I., Elias, J.A., Voelkel, N.F., and Henson, P.M. 2003. Apoptosis and emphysema: the missing link. Am. J. Respir. Cell Mol. Biol. 28:551-554.
65. Churg, A., Wang, R.D., Xie, C., and Wright, J.L. 2003. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 168:199-207.
66. Petrache, I., et al. 2006. α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol. 169:1155-1166.
67. Lewis, E.C., Shapiro, L., Bowers, O.J., and Dinarello, C.A. 2005. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. U. S. A. 102:12153-12158.
68. Fujita, M., et al. 2001. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L39-L49.
69. Singh, A., et al. 2006. Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am. J. Respir. Cell Mol. Biol. 35:639-650.
70. Rangasamy, T., et al. 2004. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114:1248-1259.
71. Johnson, G.B., Brunn, G.J., Kodaira, Y., and Platt, J.L. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:5233- 5239.
72. Maes, T., et al. 2006. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int. Arch. Allergy Immunol. 141:354-368.
73. Petrache, I., et al. 2005. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 11:491-498.
74. Gebel, S., et al. 2006. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol. Sci. 93:422-431.
75. Pisetsky, D.S. 2007. The role of nuclear macromolecules in innate immunity. Proc. Am. Thorac. Soc. 4:258-262.
76. Mahoney, J.A., and Rosen, A. 2005. Apoptosis and autoimmunity. Curr. Opin. Immunol. 17:583-588.
77. Sullivan, A.K., et al. 2005. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 172:590-596.
78. Koethe, S.M., Kuhnmuench, J.R., and Becker, C.G. 2000. Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am. J. Pathol. 157:1735-1743.
79. Lee, S.H., et al. 2007. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 13:567-569.
80. Wei, Y.Q., et al. 2000. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat. Med. 6:1160-1166.
81. Taraseviciene-Stewart, L., et al. 2006. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc. Am. Thorac. Soc. 3:687-690.
82. Robbins, C.S., et al. 2004. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am. J. Respir. Cell Mol. Biol. 30:202-211.
83. Soler, P., Moreau, A., Basset, F., and Hance, A.J. 1989. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am. Rev. Respir. Dis. 139:1112-1117.
84. Rose, N.R., and Bona, C. 1993. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today. 14:426-430.
85. Peene, I., et al. 2004. History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 17:107-116.
86. Hunt, D.P., et al. 2006. Pulmonary capillaritis and its relationship to development of emphysema in hypocomplementaemic urticarial vasculitis syndrome. Sarcoidosis Vasc. Diffuse Lung Dis. 23:70-72.
87. Ma, B., et al. 2006. Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J. Clin. Invest. 116:1274-1283.
88. Blackburn, M.R., et al. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192:159-170.
89. Harrington, E.O., Smeglin, A., Parks, N., Newton, J., and Rounds, S. 2000. Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38alpha. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L733-L742.
90. Jeffery, P.K. 1999. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin. Exp. Allergy. 29(Suppl. 2):14-26.
91. Hodge, S., Hodge, G., Holmes, M., and Reynolds, P.N. 2005. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 25:447-454.
92. Kasahara, Y., et al. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163:737-744.
93. Zhong, C.Y., Zhou, Y.M., Joad, J.P., and Pinkerton, K.E. 2006. Environmental tobacco smoke suppresses nuclear factor-kappaB signaling to increase apoptosis in infant monkey lungs. Am. J. Respir. Crit. Care Med. 174:428-436.
94. Liebow, A.A. 1959. Pulmonary emphysema with special reference to vascular changes. Am. Rev. Respir. Dis. 80:67-93.
95. Santos, S., et al. 2002. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur. Respir. J. 19:632-638.
96. Shapiro, S.D. 2000. Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. J. Clin. Invest. 106:1309-1310.
97. Voelkel, N., and Taraseviciene-Stewart, L. 2005. Emphysema: an autoimmune vascular disease? Proc. Am. Thorac. Soc. 2:23-25.
98. Wright, J.L., Tai, H., and Churg, A. 2006. Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig. J. Appl. Physiol. 100:672-678.
99. Yamato, H., Sun, J.P., Churg, A., and Wright, J.L. 1996. Cigarette smoke-induced emphysema in guinea pigs is associated with diffusely decreased capillary density and capillary narrowing. Lab. Invest. 75:211-219.
100. Voelkel, N.F., Vandivier, R.W., and Tuder, R.M. 2006. Vascular endothelial growth factor in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L209-L221.
101. Fehrenbach, H., Kasper, M., Haase, M., Schuh, D., and Muller, M. 1999. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat. Rec. 254:61-73.
102. Tang, K., Rossiter, H.B., Wagner, P.D., and Breen, E.C. 2004. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J. Appl. Physiol. 97:1559-1566.
103. Lammert, E., et al. 2003. Role of VEGF-A in vascularization of pancreatic islets. Curr. Biol. 13:1070-1074.
104. Eremina, V., et al. 2006. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J. Am. Soc. Nephrol. 17:724-735.
105. Lee, S., et al. 2007. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 130:691-703.
106. Stevens, T., Kasper, M., Cool, C., and Voelkel, N. 2005. Pulmonary circulation and pulmonary hypertension. In Endothelial cells in health and disease. W.C. Aird, editor. Taylor & Francis Group. Boca Raton, Florida, USA. 417-438.
107. Nana-Sinkam, P.S., et al. 2007. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am. J. Respir. Crit. Care Med. 175:676-685.
108. Ziel, K.A., et al. 2005. Oxidants in signal transduction: impact on DNA integrity and gene expression. FASEB J. 19:387-394.
109. Golpon, H.A., et al. 2004. Emphysema lung tissue gene expression profiling. Am. J. Respir. Cell Mol. Biol. 31:595-600.
110. Takahashi, A., et al. 2006. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8:1291-1297.
111. Sato, T., et al. 2006. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am. J. Respir. Crit Care Med. 174:530-537.
112. Massaro, D., Massaro, G.D., Baras, A., Hoffman, E.P., and Clerch, L.B. 2004. Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression. Am. J. Physiol Lung Cell Mol. Physiol. 286:L896-L906.
113. Thet, L.A., Delaney, M.D., Gregorio, C.A., and Massaro, D. 1977. Protein metabolism by rat lung: influence of fasting, glucose, and insulin. J. Appl. Physiol. 43:463-467.
114. Coxson, H.O., et al. 2004. Early emphysema in patients with anorexia nervosa. Am. J. Respir. Crit. Care Med. 170:748-752.
115. Shifren, A., and Mecham, R.P. 2006. The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc. Am. Thorac. Soc. 3:428-433.
116. Tanaka, N., Tajima, S., Ishibashi, A., Uchida, K., and Shigematsu, T. 2001. Immunohistochemical detection of lipid peroxidation products, protein-bound acrolein and 4-hydroxynonenal protein adducts, in actinic elastosis of photodamaged skin. Arch. Dermatol. Res. 293:363-367.
117. Wu, C.C., et al. 2006. Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol. Appl. Pharmacol. 214:244-252.
118. Fujioka, K., and Shibamoto, T. 2006. Determination of toxic carbonyl compounds in cigarette smoke. Environ. Toxicol. 21:47-54.
119. Uchida, K., et al. 1998. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 95:4882-4887.
120. Ito, K., et al. 2005. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352:1967-1976.
121. Szulakowski, P., et al. 2006. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174:41-50.
122. Suratt, B.T., et al. 2003. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am. J. Respir. Crit. Care Med. 168:318-322.
123. Bonsignore, M.R., et al. 2006. Circulating CD34+ cells are decreased in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 3:537-538.
124. Hattori, K., et al. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193:1005-1014.
125. Kotton, D.N., and Fine, A. 2008. Lung stem cells. Cell Tissue Res. 331:145-156.